Despite evidence that NGAL is a potential biomarker for alveolar or bronchial epithelial cell damage, the concentration of NGAL required for predicting the outcome of ARDS and the severity of lung injury is still unknown. This evidence concerns the gene LCN2 and acute respiratory distress syndrome.